OSFopen access
TRANSCEND-T2D-1 and the First-Line Question: What Retatrutide's Phase 3 Results Mean for Diabetes Care, Access & Equity
Medical Sociology, GLP-1 receptor agonists, type 2 diabetes, pharmaceutical policy, Race, Gender, and Class, Social and Behavioral Sciences
This document is indexed with metadata only — full text is not available in the archive for this record.
Open the official source ↗Related documents
Record · ID 302262
Retrieved via
Conceptio — every document is proof-bundled with source, license, and retrieval metadata.